Anti-lipidemic Effect of Fractions of Peristrophe bivalvis Leaf in NG-nitro-L-arginine Methyl Ester (L-NAME) Treated Rats. 2020

Esther Oluwasola Aluko, and Temidayo Olutayo Omobowale, and Ademola Adetokunbo Oyagbemi, and Adesoji Adedipe Fasanmade
Physiology Department, Faculty of Basic Medical Sciences, University of Uyo, Nigeria.

OBJECTIVE The reduction in nitric oxide (NO) bioavailability accelerates atherosclerosis development, augments lipolysis, elevates blood pressure and upregulate leukocyte level. This study was designed to examine the biochemical constituents of fractions of Peristrophe bivalvis (PB) leaf, their effect on blood pressure, serum lipid contents and complete blood count in NG-nitro-L-arginine methyl ester (L-NAME) hypertensive rats. METHODS Male Wistar rats were grouped into control and hypertensive groups. The hypertensive group was pretreated with 60 mg/kg b.w of L-NAME (L-NAME60) daily for two weeks. They were then randomly sub-grouped into: Hypertensive (H), Hypertensive+n-hexane fraction (HHF), Hypertensive+dichloromethane fraction (HDF), Hypertensive+ethyl acetate fraction (HEF) and Hypertensive+aqueous fraction (HAF) groups. These were orally gavaged with L-NAME60 and L-NAME60+200 mg/kg b.w of fractions of PB respectively, daily for two weeks. RESULTS The biochemical components analysis of the fractions of PB identified numerous polar and non polar compounds like alkaloids, organic acids and esters. The results showed a significant increase in NO level in HHF and HEF groups compared to H. Total cholesterol, triglyceride, low density lipoprotein cholesterol (LDL-C) and very LDL-C were significantly decreased in HAF group compared to H. High density lipoprotein cholesterol (HDL-C) increased significantly and atherogenic indices decreased significantly in HHF, HDF and HAF groups compared to H, while reduced glutathione level increased significantly in HHF group compared to H. White blood cells count effectively decreased in HEF group compared to H. CONCLUSIONS In brief, the fractions of PB leaf increased HDL-C and NO, and decrease atherogenic indices in L-NAME treated rats.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008076 Cholesterol, HDL Cholesterol which is contained in or bound to high-density lipoproteins (HDL), including CHOLESTEROL ESTERS and free cholesterol. High Density Lipoprotein Cholesterol,Cholesterol, HDL2,Cholesterol, HDL3,HDL Cholesterol,HDL(2) Cholesterol,HDL(3) Cholesterol,HDL2 Cholesterol,HDL3 Cholesterol,alpha-Lipoprotein Cholesterol,Cholesterol, alpha-Lipoprotein,alpha Lipoprotein Cholesterol
D008078 Cholesterol, LDL Cholesterol which is contained in or bound to low density lipoproteins (LDL), including CHOLESTEROL ESTERS and free cholesterol. LDL Cholesterol,Cholesteryl Linoleate, LDL,LDL Cholesteryl Linoleate,Low Density Lipoprotein Cholesterol,beta-Lipoprotein Cholesterol,Cholesterol, beta-Lipoprotein,beta Lipoprotein Cholesterol
D008297 Male Males
D009569 Nitric Oxide A free radical gas produced endogenously by a variety of mammalian cells, synthesized from ARGININE by NITRIC OXIDE SYNTHASE. Nitric oxide is one of the ENDOTHELIUM-DEPENDENT RELAXING FACTORS released by the vascular endothelium and mediates VASODILATION. It also inhibits platelet aggregation, induces disaggregation of aggregated platelets, and inhibits platelet adhesion to the vascular endothelium. Nitric oxide activates cytosolic GUANYLATE CYCLASE and thus elevates intracellular levels of CYCLIC GMP. Endogenous Nitrate Vasodilator,Mononitrogen Monoxide,Nitric Oxide, Endothelium-Derived,Nitrogen Monoxide,Endothelium-Derived Nitric Oxide,Monoxide, Mononitrogen,Monoxide, Nitrogen,Nitrate Vasodilator, Endogenous,Nitric Oxide, Endothelium Derived,Oxide, Nitric,Vasodilator, Endogenous Nitrate
D010936 Plant Extracts Concentrated pharmaceutical preparations of plants obtained by removing active constituents with a suitable solvent, which is evaporated away, and adjusting the residue to a prescribed standard. Herbal Medicines,Plant Extract,Extract, Plant,Extracts, Plant,Medicines, Herbal
D001772 Blood Cell Count The number of LEUKOCYTES and ERYTHROCYTES per unit volume in a sample of venous BLOOD. A complete blood count (CBC) also includes measurement of the HEMOGLOBIN; HEMATOCRIT; and ERYTHROCYTE INDICES. Blood Cell Number,Blood Count, Complete,Blood Cell Counts,Blood Cell Numbers,Blood Counts, Complete,Complete Blood Count,Complete Blood Counts,Count, Blood Cell,Count, Complete Blood,Counts, Blood Cell,Counts, Complete Blood,Number, Blood Cell,Numbers, Blood Cell
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Esther Oluwasola Aluko, and Temidayo Olutayo Omobowale, and Ademola Adetokunbo Oyagbemi, and Adesoji Adedipe Fasanmade
June 1992, British journal of pharmacology,
Esther Oluwasola Aluko, and Temidayo Olutayo Omobowale, and Ademola Adetokunbo Oyagbemi, and Adesoji Adedipe Fasanmade
October 2019, Life sciences,
Esther Oluwasola Aluko, and Temidayo Olutayo Omobowale, and Ademola Adetokunbo Oyagbemi, and Adesoji Adedipe Fasanmade
December 2022, Archives of physiology and biochemistry,
Esther Oluwasola Aluko, and Temidayo Olutayo Omobowale, and Ademola Adetokunbo Oyagbemi, and Adesoji Adedipe Fasanmade
April 1995, British journal of pharmacology,
Esther Oluwasola Aluko, and Temidayo Olutayo Omobowale, and Ademola Adetokunbo Oyagbemi, and Adesoji Adedipe Fasanmade
July 2020, Journal of ethnopharmacology,
Esther Oluwasola Aluko, and Temidayo Olutayo Omobowale, and Ademola Adetokunbo Oyagbemi, and Adesoji Adedipe Fasanmade
July 1996, British journal of pharmacology,
Esther Oluwasola Aluko, and Temidayo Olutayo Omobowale, and Ademola Adetokunbo Oyagbemi, and Adesoji Adedipe Fasanmade
June 1994, The Journal of pharmacy and pharmacology,
Esther Oluwasola Aluko, and Temidayo Olutayo Omobowale, and Ademola Adetokunbo Oyagbemi, and Adesoji Adedipe Fasanmade
July 2004, Biochemical pharmacology,
Esther Oluwasola Aluko, and Temidayo Olutayo Omobowale, and Ademola Adetokunbo Oyagbemi, and Adesoji Adedipe Fasanmade
November 1995, Methods and findings in experimental and clinical pharmacology,
Esther Oluwasola Aluko, and Temidayo Olutayo Omobowale, and Ademola Adetokunbo Oyagbemi, and Adesoji Adedipe Fasanmade
January 1995, Nephron,
Copied contents to your clipboard!